Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

ASMB US Equity

Assembly Biosciences, Inc.Health Care · Pharmaceutical Preparations · CIK 1426800 · FY ends Dec 31
$33.84
+1.71 (+5.32%)
USD · as of 2026-08-19 · marketstack
2 8-K filings · 0 13D · 3 13G
DateEventWhat happened / filerSource
2026-08-1413G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by Paradigm Biocapital Advisors LPsec.gov ↗
2026-08-148-K 2.02Results of operations and financial condition (earnings) (amendment)earnings history (EARN) →sec.gov ↗
2026-08-138-K 2.01Completion of acquisition or disposition of assetssec.gov ↗
2026-08-1313G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by Janus Henderson Group Ltd.sec.gov ↗
2026-08-0413G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by FARALLON CAPITAL MANAGEMENT, L.L.C.sec.gov ↗
Source: SEC EDGAR (public domain) · history starts 2026-08-04

Every row is a filed document, checked against its EDGAR index.